Stem definition | Drug id | CAS RN |
---|---|---|
3323 | 60-33-3 |
None
None
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatotoxicity | 64.97 | 46.73 | 16 | 167 | 37025 | 63451814 |
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatotoxicity | 57.62 | 50.99 | 16 | 244 | 51336 | 79692792 |
Regurgitation | 53.25 | 50.99 | 9 | 251 | 2778 | 79741350 |
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:76924 | plant metabolites |
CHEBI has role | CHEBI:83038 | Daphnia galeata metabolites |
CHEBI has role | CHEBI:84735 | algal metabolites |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.76 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Prostaglandin G/H synthase 1 | Enzyme | IC50 | 4.89 | CHEMBL | |||||
Aromatase | Enzyme | IC50 | 4.32 | CHEMBL | |||||
Aldo-keto reductase family 1 member C3 | Enzyme | IC50 | 6.16 | CHEMBL | |||||
Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | Kd | 8.32 | CHEMBL | |||||
Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | IC50 | 5.21 | CHEMBL | |||||
Fatty acid-binding protein, adipocyte | Cytosolic other | IC50 | 6 | CHEMBL | |||||
Fatty acid-binding protein, heart | Cytosolic other | Kd | 9.70 | CHEMBL | |||||
Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | IC50 | 5 | CHEMBL | |||||
Free fatty acid receptor 1 | GPCR | AGONIST | EC50 | 5.70 | IUPHAR | ||||
Potassium voltage-gated channel subfamily B member 1 | Ion channel | ACTIVATOR | EC50 | 5.60 | IUPHAR | ||||
Tissue factor | Membrane receptor | IC50 | 4.39 | CHEMBL | |||||
Free fatty acid receptor 4 | GPCR | AGONIST | EC50 | 5.89 | IUPHAR | ||||
Nuclear receptor subfamily 4 group A member 2 | Nuclear other | Kd | 4.30 | CHEMBL | |||||
Adenosine receptor A1 | GPCR | IC50 | 4.19 | CHEMBL | |||||
Seed linoleate 13S-lipoxygenase-1 | Enzyme | IC50 | 6 | CHEMBL | |||||
Prostaglandin G/H synthase 2 | Enzyme | IC50 | 4.03 | CHEMBL |
ID | Source |
---|---|
4020238 | VUID |
N0000148142 | NUI |
4020238 | VANDF |
C0023749 | UMLSCUI |
CHEBI:17351 | CHEBI |
EIC | PDB_CHEM_ID |
CHEMBL267476 | ChEMBL_ID |
DB14104 | DRUGBANK_ID |
D019787 | MESH_DESCRIPTOR_UI |
5280450 | PUBCHEM_CID |
1052 | IUPHAR_LIGAND_ID |
9KJL21T0QJ | UNII |
6400 | RXNORM |
005003 | NDDF |
012326 | NDDF |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
PrimaCare | HUMAN PRESCRIPTION DRUG LABEL | 14 | 75854-322 | PILL | 50 mg | oral | unapproved drug other | 11 sections |
Dr.Different VITAACNAL TX Capsule Serum | HUMAN OTC DRUG LABEL | 2 | 81710-110 | LIQUID | 0.76 g | TOPICAL | unapproved drug other | 8 sections |
Anubis Barcelona Vital Line | HUMAN OTC DRUG LABEL | 23 | 83021-064 | CREAM | 0.16 g | TOPICAL | OTC monograph final | 5 sections |
AnubisMed | HUMAN OTC DRUG LABEL | 28 | 83021-551 | CREAM | 0.50 g | TOPICAL | OTC monograph final | 7 sections |
Anubis Barcelona Protective Line | HUMAN OTC DRUG LABEL | 27 | 83021-686 | CREAM | 0.50 g | TOPICAL | OTC monograph final | 9 sections |
Anubis Barcelona Protective Line | HUMAN OTC DRUG LABEL | 27 | 83021-686 | CREAM | 0.50 g | TOPICAL | OTC monograph final | 9 sections |